» Articles » PMID: 36564944

Association of Weight Change and In-hospital Mortality in Patients with Repeated Hospitalization for Heart Failure

Abstract

Background: Although weight loss in heart failure (HF) is a detrimental condition known as cachexia, weight gain caused by fluid retention should also be considered harmful. However, studies with sufficient number of patients examining the impact of weight change and its interval on in-hospital mortality in HF have not been conducted thus far. We sought to elucidate the association of weight change with in-hospital mortality in patients with HF.

Methods: This retrospective observational study used data from the Diagnosis Procedure Combination database, a nationwide inpatient health claims database in Japan. In total, 48 234 patients repeatedly hospitalized for HF (median 82 [74-87] years; 46.4% men) between 2010 and 2018 were included. Weight change was derived from body weight at the first and second admissions.

Results: The median weight change and interval between two hospitalizations were -3.1 [-8.3 to -1.8] % and 172 [67-420] days, with 66.9% of overall cohort experiencing any weight loss. As a result of multivariable-adjusted logistic regression analysis, weight loss <-5.0% and weight gain >+5.0% were associated with increased in-hospital mortality (adjusted odds ratio [OR] [95% confidence interval]: 1.46 [1.31-1.62], P < 0.001 and 1.23 [1.08-1.40], P = 0.002, respectively) whereas mild weight loss and gain of 2.0-5.0% were not (OR [95% confidence interval]: 0.96 [0.84-1.10], P = 0.57 and 1.07 [0.92-1.25], P = 0.37, respectively), in comparison with patients with a stable weight (fluctuating no more than -2.0% to +2.0%) used as a reference. Restrictive cubic spline models adjusted for multiple background factors illustrated that higher mortality in patients with weight loss was observed across all subgroups of the baseline body mass index (<18.5, 18.5-24.9 and ≥25.0 kg/m ). In patients with short (<90 days) and middle (<180 days) intervals between the two hospitalizations, both weight loss and weight gain were associated with high mortality, whereas the association between weight gain and high mortality was attenuated in those with longer intervals.

Conclusions: Both weight loss and weight gain in patients with repeated hospitalization for HF were associated with high in-hospital mortality, especially weight loss and short/middle-term weight gain. Such patients should be treated with caution in a setting of repeated hospitalization for HF.

Citing Articles

Prevalence and Prognostic Value of Cachexia Diagnosed by New Definition for Asian People in Older Patients With Heart Failure.

Noda T, Maekawa E, Maeda D, Uchida S, Yamashita M, Hamazaki N J Cachexia Sarcopenia Muscle. 2024; 15(6):2660-2668.

PMID: 39500719 PMC: 11634483. DOI: 10.1002/jcsm.13610.


Prognostic influence of weight loss on overweight/obese young heart failure patients.

He S, Guan X, Zhang J Saudi Med J. 2024; 45(4):349-355.

PMID: 38657976 PMC: 11147568. DOI: 10.15537/smj.2024.45.4.20230765.


Predicting Mortality Risks Using Body Mass Index and Weight Loss at Admission in Patients with Heart Failure.

Ishida Y, Maeda K, Murotani K, Shimizu A, Ueshima J, Nagano A Ann Geriatr Med Res. 2024; 28(2):171-177.

PMID: 38475664 PMC: 11217663. DOI: 10.4235/agmr.23.0213.


Diagnosis and outcomes of cachexia in Asia: Working Consensus Report from the Asian Working Group for Cachexia.

Arai H, Maeda K, Wakabayashi H, Naito T, Konishi M, Assantachai P J Cachexia Sarcopenia Muscle. 2023; 14(5):1949-1958.

PMID: 37667992 PMC: 10570088. DOI: 10.1002/jcsm.13323.


Association of weight change and in-hospital mortality in patients with repeated hospitalization for heart failure.

Konishi M, Kaneko H, Itoh H, Matsuoka S, Okada A, Kamiya K J Cachexia Sarcopenia Muscle. 2022; 14(1):642-652.

PMID: 36564944 PMC: 9891958. DOI: 10.1002/jcsm.13170.

References
1.
Nabel E, Braunwald E . A tale of coronary artery disease and myocardial infarction. N Engl J Med. 2012; 366(1):54-63. DOI: 10.1056/NEJMra1112570. View

2.
Blair J, Khan S, Konstam M, Swedberg K, Zannad F, Burnett Jr J . Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial. Eur Heart J. 2009; 30(13):1666-73. DOI: 10.1093/eurheartj/ehp144. View

3.
Kamisaka K, Kamiya K, Iwatsu K, Iritani N, Imoto S, Adachi T . Impact of weight loss in patients with heart failure with preserved ejection fraction: results from the FLAGSHIP study. ESC Heart Fail. 2021; 8(6):5293-5303. PMC: 8712923. DOI: 10.1002/ehf2.13619. View

4.
Fearon K, Strasser F, Anker S, Bosaeus I, Bruera E, Fainsinger R . Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011; 12(5):489-95. DOI: 10.1016/S1470-2045(10)70218-7. View

5.
Martin L, Senesse P, Gioulbasanis I, Antoun S, Bozzetti F, Deans C . Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol. 2014; 33(1):90-9. DOI: 10.1200/JCO.2014.56.1894. View